HBV News and Research

RSS
FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

New vaccine against grass pollen allergies may help combat hepatitis B infection

New vaccine against grass pollen allergies may help combat hepatitis B infection

New report urges all European countries to adopt universal vaccination for hepatitis

New report urges all European countries to adopt universal vaccination for hepatitis

New screen-and-treat programme for hepatitis B may thwart deadly complications of disease

New screen-and-treat programme for hepatitis B may thwart deadly complications of disease

AAPS Foundation announces winner of 2016 New Investigator Grant

AAPS Foundation announces winner of 2016 New Investigator Grant

FIB-4 index predicts HBV-related HCC

FIB-4 index predicts HBV-related HCC

Infant HBV vaccination prevents HCC in children, young adults

Infant HBV vaccination prevents HCC in children, young adults

TDF reduces vertical HBV transmission

TDF reduces vertical HBV transmission

'Simple' model predicts PegIFN response in chronic HBV

'Simple' model predicts PegIFN response in chronic HBV

HCC predictors identified for chronic HBV patients with newly diagnosed cirrhosis

HCC predictors identified for chronic HBV patients with newly diagnosed cirrhosis

Maternal HBsAg can serve as HBV vertical transmission marker

Maternal HBsAg can serve as HBV vertical transmission marker

Panel of microRNAs can predict patients at risk for developing HBV-driven liver cancer

Panel of microRNAs can predict patients at risk for developing HBV-driven liver cancer

Hepatitis B virus screening for Asian American adults can help prevent onset of liver diseases

Hepatitis B virus screening for Asian American adults can help prevent onset of liver diseases

HBcrAg may predict HCC development

HBcrAg may predict HCC development

WFA+-M2BP levels linked to liver fibrosis, HCC progression in chronic HBV

WFA+-M2BP levels linked to liver fibrosis, HCC progression in chronic HBV

Serum marker may flag liver fibrosis in chronic HBV

Serum marker may flag liver fibrosis in chronic HBV

Resolving HBV infection does not reduce liver cancer risk

Resolving HBV infection does not reduce liver cancer risk

TDF, entecavir duo 'highly effective' for difficult-to-treat chronic HBV

TDF, entecavir duo 'highly effective' for difficult-to-treat chronic HBV